FIN 301-MODULE1-SLP - TUI University FIN 301 Module 1 SLP...

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon
TUI University FIN 301 Module 1 SLP Assignment
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
The company I will be discussing is Accentia Biopharmaceuticals, Inc. which is a company focused on commercializing products based on discoveries in the field of immunology. Its products include SinuNase for the treatment of chronic rhinosinusitis; BiovaxID, a patient-specific agent that fights against diseases that causes cancer. One of the reasons I choose this company is not by name but Industry. Anytime a company can commercialize and develop drugs for human consumption should be an eye opener. There are millions of drugs on the market and one has to question the authenticity of these drugs. These publicly traded companies have a legal responsibility to increase profits. Have you ever listened to all the side affects when listening to the commercial? It may cause this, or it may cause that. What I personally find interesting is not the profits they generate but how the
Background image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 4

FIN 301-MODULE1-SLP - TUI University FIN 301 Module 1 SLP...

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online